The routine commissioning of bevacizumab is accepted for use prior to vitrectomy in patients with proliferative diabetic retinopathy.
| Filename: | Anti vascular endothelial growth factor drugs for use prior to vitrectomy in patients with proliferative diabetic retinopathy |
| Filetype: | |
| Filesize: | 54.29 KB |
| Date uploaded: | 22nd June 2011 |
| Date updated: | 8th December 2022 |
